Clinical and pharmacokinetic data of a docetaxel-epirubicin combination in metastatic breast cancer

This publication has 23 references indexed in Scilit:

• THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS
  Annual Review of Medicine, 1997
• Characterisation of complete responders to combination chemotherapy for advanced breast cancer: A retrospective EORTC breast group study
  European Journal Of Cancer, 1996
• Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic
  Annals of Oncology, 1996
• Treatment of patients resistant to anthracycline therapy
  Anti-Cancer Drugs, 1996
• Docetaxel
  Drugs, 1996
• Docetaxel (Taxotere®), a review of preclinical and clinical experience. Part II
  Anti-Cancer Drugs, 1995
• Measurement of Cremophor EL Following Taxol: Plasma Levels Sufficient to Reverse Drug Exclusion Mediated by the Multidrug-Resistant Phenotype
  JNCI Journal of the National Cancer Institute, 1993
• Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicity
  Cancer Treatment Reviews, 1993
• BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
  Annual Review of Biochemistry, 1993
• Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method
  Journal of Chromatography B: Biomedical Sciences and Applications, 1992